1. Introduction {#sec1-pathogens-08-00099}
===============

*Leishmania infantum* is a protozoan parasite responsible for canine leishmaniosis (CanL) and infantile kala-azar in Italy and in Mediterranean countries \[[@B1-pathogens-08-00099]\], with dogs as the main reservoirs for the parasite. In South European endemic areas, other infected carnivores have been reported, in particular cats \[[@B2-pathogens-08-00099],[@B3-pathogens-08-00099],[@B4-pathogens-08-00099]\], foxes \[[@B5-pathogens-08-00099],[@B6-pathogens-08-00099],[@B7-pathogens-08-00099]\], wolves \[[@B8-pathogens-08-00099]\], mustelids, and viverrids \[[@B9-pathogens-08-00099]\].

On the other hand, rodents such as black rats \[[@B10-pathogens-08-00099]\] and hares \[[@B11-pathogens-08-00099],[@B12-pathogens-08-00099],[@B13-pathogens-08-00099]\] have previously been described as being infected. Moreover, bovine \[[@B14-pathogens-08-00099]\] and horses were proven to be affected by cutaneous leishmaniosis in both Central \[[@B15-pathogens-08-00099],[@B16-pathogens-08-00099]\] and Southern Europe \[[@B17-pathogens-08-00099],[@B18-pathogens-08-00099],[@B19-pathogens-08-00099]\]. Wallabies and orangutans have also recently been recognized as being affected, in Spain \[[@B20-pathogens-08-00099],[@B21-pathogens-08-00099]\].

Donkeys are reported to develop clinical leishmaniosis \[[@B22-pathogens-08-00099],[@B23-pathogens-08-00099],[@B24-pathogens-08-00099]\] in South America; *Leishmania braziliensis* was recognized as aetiological agent \[[@B25-pathogens-08-00099]\] and equids such horses, donkeys and mules are suspected reservoir for *L. braziliensis* in endemic areas \[[@B26-pathogens-08-00099]\]. Furthermore, donkeys were shown to be sensitive to infection from *Leishmania chagasi* (*L. infantum*), showing positive serology and occurrence of parasites in tissues, although with a negative xenodiagnosis \[[@B27-pathogens-08-00099]\]. Recent studies carried out in *Leishmania donovani* endemic foci in Ethiopia detected a high seropositivity rate in donkeys \[[@B28-pathogens-08-00099]\], parasite DNA and a widespread exposure to sandfly saliva \[[@B29-pathogens-08-00099]\]. Just recently, in Portugal, 1 donkey out of 186 was found to be seropositive \[[@B30-pathogens-08-00099]\]. Furthermore, *Phlebotomus orientalis*, a proven vector of *L. donovani,* showed zoophilic feeding preferences, with a predominant choice for bovine, followed by donkey \[[@B31-pathogens-08-00099]\], indicating that this latter species is a preferred source for bloodmeal, with a higher engorgement rate for the sandfly female \[[@B32-pathogens-08-00099]\].

Tuscany (Central Italy) is an endemic area for canine leishmaniosis. In this region, donkey breeding is extensively managed, and autochthonous breeds, which are employed in recreational activities, onotherapy and milk production, are preserved.

Data on the occurrence of *Leishmania* infection in donkeys from Europe are very rare. For these reasons, the aim of the present study was to evaluate the presence of parasite DNA in buffy coat and of specific antibodies in serum from jennies, living in a CanL endemic area in Tuscany.

2. Results {#sec2-pathogens-08-00099}
==========

The results showed that 33 specimens out of 110 scored IFAT positive, with titers ranging from 40 to 320. In detail, 11 animals out of 30 (36.7%) showed an antibody response. In addition, 22two out of the other 37 jennies also obtained positive scores. Moreover, 2 animals that were submitted to 2 and 3 blood samplings, respectively, had positive results for both samplings.

Blood specimens collected in June scored positive for *Leishmania* DNA in two animals, with weak IFAT titers.

Serological and molecular findings, along with sampling time, are reported in [Table 1](#pathogens-08-00099-t001){ref-type="table"}.

3. Discussion {#sec3-pathogens-08-00099}
=============

The seroprevalence of anti-*Leishmania* antibodies in the present study was strikingly high (36.7%), in a population of healthy jennies. All of the subjects submitted to repeated sampling showed fleeting antibody titers. Most of them in fact, scored positive once, except for 2 animals that developed a further response after an apparent winter negativization, when examined during the transmission season. This finding would suggest a possible parasite clearance, which might be due to an effective immunological response, corroborating the hypothesis of an intrinsic species resistance of donkeys to *Leishmania* parasites. IFAT was selected for serological evaluation, following similar studies performed on horses from Brazil \[[@B33-pathogens-08-00099]\], even if its accuracy in the diagnosis of canine leishmaniasis is reported as declining in samples from endemic regions \[[@B34-pathogens-08-00099]\].

Our findings would allow us to hypothesize that *P. perniciosus*, the mostly occurring sandfly species in the study area \[[@B35-pathogens-08-00099],[@B36-pathogens-08-00099]\], may have a host-feeding preference for donkeys, according to Gebresilassie et al. \[[@B31-pathogens-08-00099]\].

To the best of our knowledge, the present study is the first in Europe to evaluate the presence of *Leishmania* DNA in donkeys' blood, and the first in Italy referring to serological data in this animal species, with a transversal study from Portugal being the only previous European record, with a seroprevalence of about 0.5%. \[[@B28-pathogens-08-00099]\] In the present study, striking seroprevalences in this animal species, with a longitudinal evaluation of serological changes, were reported.

In a similar study carried out on healthy horses from Spain \[[@B37-pathogens-08-00099]\] a lower seroprevalence was reported, moreover, specific lymphocyte proliferation was observed in 36.4% of the investigated animals, suggesting, along with the low occurrence of clinical patent leishmaniosis, the efficacy of the cell mediated immune response.

The high seroprevalence, together with the lack of reports of *L. infantum* clinical cases in donkey in Europe, would suggest a strong resistance of this animal species versus the parasite, as well as a high exposure degree to infected vectors. Buffy coat for *Leishmania* does not represent the most sensitive tissue, so the detection of 2 positive samples would indicate an active parasite circulation among the tested jennies. Our finding would suggest the role of this species as a potential reservoir for this protozoan agent.

4. Materials and Methods {#sec4-pathogens-08-00099}
========================

A total of 110 serum samples (1 mL each) were obtained from 67 healthy lactating Amiatina jennies, aged from 4 to 18 years. The animals were semi-extensively reared near Scarlino (42°54′28″N 10°51′05″E), Tuscany, in an area where canine leishmaniosis has a seroprevalence of about 20% (unpublished data). All the animals were living in the breeding farm for at least two transmission seasons. Repellent and insecticidal treatments were not applied to all of the donkeys. Dogs were neither present in the farm, nor in the wider environment.

Sera from 30 jennies, already serologically processed for *Toxoplasma gondii* and piroplasms, were used in the present study in order to estimate a seroprevalence rate. Blood specimens from the remaining animals were collected to carry out genetic analysis about dairy genes. The samples were obtained from 37 animals. If available, specimens were drawn at about 3, 6 and 10 months after parturition. In detail, 15 of 37 animals had a unique blood sampling, 1 jenny yielded 2 specimens, and from the other 21 animals, 3 blood samples were obtained. Furthermore, blood samples added to Ethylenediaminetetraacetic acid (EDTA) were drawn from the 37 animals for parasitological molecular testing.

All serum samples were used to carry out IFAT in order to detect anti-*Leishmania* antibodies. The testing was conducted as previously reported for canine leishmaniosis \[[@B38-pathogens-08-00099]\] diagnosis, using an anti-horse IgG FITC (Sigma Aldrich, Italy) as a secondary antibody, diluted 1:30. The cut-off value was put at 1/40, as reported by Soares et al. \[[@B39-pathogens-08-00099]\].

Whole blood samples were processed for molecular purposes. DNA was extracted from 200 µL of buffy coat by blood/cultured cells genomic DNA extraction mini kit (Trevose, PA, USA) and all samples were submitted to PCR assay. For detection of Leishmania DNA, the ITS1 gene was selected as PCR target, as previously described \[[@B13-pathogens-08-00099]\]. PCR amplifications were performed in 50 μL of reaction mixture, containing 200 μM of deoxynucleoside triphosphates, 0.5 μM of each primer, 1.25 U of Taq polymerase (Lucigen Corporation, Middleton, Wisconsin, USA), and 2 μL of genomic DNA. All amplifications were performed using an automated thermal cycler Gene-Amp PCR System 2700 (Perkin Elmer, Norwalk, Connecticut, USA).

PCR products were then analyzed by electrophoresis on 1.5% agarose gel at 100 V for 45 min; the gel was stained with ethidium bromide and observed. SharpMassTM 100 Plus Ladder (Euroclone, Milano, Italy) was used as a DNA marker.

5. Conclusions {#sec5-pathogens-08-00099}
==============

The preliminary results obtained in the present paper show a high seroprevalence for *Leishmania* in examined donkeys, as well as the occurrence of parasite DNA in blood. Additional studies would be welcome, both to further investigate the kinetics of antibody response over a longer time and to elucidate the role of donkey in *Leishmania* epidemiology of CanL endemic areas, in order to confirm the preliminary findings and the hypothesis proposed here.
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###### 

Age, sampling time and serological findings of positive animals.

  N. Jenny       Age (years)       Month of Sampling       IFAT Titer
  -------------- ----------------- ----------------------- ----------------
  1              15                July 2016               1/80
  2              7                 July 2016               1/80
  3              5                 July 2016               1/80
  4              12                July 2016               1/40
  5              17                July 2016               1/40
  6              4                 July 2016               1/40
  7              9                 July 2016               1/40
  8              5                 July 2016               1/80
  9              10                July 2016               1/40
  10             4                 July 2016               1/80
  11             10                July 2016               1/80
  12             13                June 2017               1/160
  **N. Jenny**   **Age (years)**   **Month of Sampling**   **IFAT Titer**
  12                               March 2018              neg
  13             10                July 2017               1/80
  14             10                June 2017               1/80
  14                               October 2017            neg
  14                               May 2018                neg
  15             9                 November 2017           1/80
  15                               March 2018              neg
  16             17                January 2018            1/320
  16                               July 2018               neg
  16                               October 2018            neg
  17             10                June 2017               1/160
  18             6                 October 2017            1/160
  18                               March 2018              neg
  18                               July 2018               1/40
  19             6                 June 2017               1/80\*
  19                               October 2017            neg
  19                               March 2018              neg
  20             5                 January 2018            neg
  20                               June 2018               1/40
  20                               October 2018            1/160
  21             5                 May 2017                1/80
  21                               October 2017            1/80
  21                               March 2018              neg
  22             5                 November 2017           neg
  22                               June 2018               1/160
  22                               October 2018            neg
  23             5                 November 2017           neg
  23                               May 2018                neg
  23                               October 2018            1/80
  24             5                 October 2017            1/160
  24                               January 2018            1/320
  24                               June 2018               neg
  25             4                 July 2018               neg
  25                               May 2018                neg
  26             4                 June 2017               1/160
  26                               October 2017            neg
  26                               May 2018                neg
  27             4                 July 2017               neg
  27                               December 2017           neg
  27                               May 2018                1/160
  28             4                 October 2017            1/160
  **N. Jenny**   **Age (years)**   **Month of Sampling**   **IFAT Titer**
  28                               January 2018            neg
  28                               June 2018               neg
  29             13                June 2017               1/40 \*

Legend: \* PCR positive specimens.
